NovaBone wins PMA for MacroForm bone repair device

Bio-active synthetic bone graft company NovaBone said today it won FDA premarket approval for its MacroForm minimally invasive bone repair device.

The device is designed to deliver bone marrow aspirate to a graft via an minimally invasive cannula, the Jacksonville, Fl.-based company said.

“The MacroForm MIS delivery system builds off the commercial success of the intuitively-designed collagen devices we have launched over the past several months. Moreover, NovaBone’s MacroForm technology, which offers more bioactivity than any other competitive product, is now available in multiple formulations, and delivery options,” sales & marketing veep Dennis McBride said in a press release.

The company said it released 6 new collagen products over the past year and claims to have the broadest portfolio of bone graft substitutes in the world, according to a press release.

“We continue to reach milestones we have established. Our team has done an excellent job in terms of both design and manufacturing of collagen products and creating a robust pipeline of products that harness the natural healing process of the body,” products prez Art Wotiz said in prepared remarks.

The post NovaBone wins PMA for MacroForm bone repair device appeared first on MassDevice.

from MassDevice http://ift.tt/1Ui8X6s